These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 15906243)

  • 1. The human T cell immune response to Epstein-Barr virus.
    Landais E; Saulquin X; Houssaint E
    Int J Dev Biol; 2005; 49(2-3):285-92. PubMed ID: 15906243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers.
    Tan LC; Gudgeon N; Annels NE; Hansasuta P; O'Callaghan CA; Rowland-Jones S; McMichael AJ; Rickinson AB; Callan MF
    J Immunol; 1999 Feb; 162(3):1827-35. PubMed ID: 9973448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel method for detection of virus-specific CD41+ T cells indicates a decreased EBV-specific CD4+ T cell response in untreated HIV-infected subjects.
    Piriou ER; van Dort K; Nanlohy NM; van Oers MH; Miedema F; van Baarle D
    Eur J Immunol; 2005 Mar; 35(3):796-805. PubMed ID: 15724243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential targeting and shifts in the immunodominance of Epstein-Barr virus--specific CD8 and CD4 T cell responses during acute and persistent infection.
    Woodberry T; Suscovich TJ; Henry LM; Davis JK; Frahm N; Walker BD; Scadden DT; Wang F; Brander C
    J Infect Dis; 2005 Nov; 192(9):1513-24. PubMed ID: 16206065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human peripheral blood and bone marrow Epstein-Barr virus-specific T-cell repertoire in latent infection reveals distinct memory T-cell subsets.
    Guerreiro M; Na IK; Letsch A; Haase D; Bauer S; Meisel C; Roemhild A; Reinke P; Volk HD; Scheibenbogen C
    Eur J Immunol; 2010 Jun; 40(6):1566-76. PubMed ID: 20232341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A11 Tetramer-assisted characterization of Rta-specific CD8+ T-cell responses in healthy virus carriers.
    Yu HX; Srinivasan N; Ren EE; Chan SH
    Tissue Antigens; 2005 Jun; 65(6):539-43. PubMed ID: 15896201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expansion of peripheral CD8+ CD28- T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis.
    Klatt T; Ouyang Q; Flad T; Koetter I; Bühring HJ; Kalbacher H; Pawelec G; Müller CA
    J Rheumatol; 2005 Feb; 32(2):239-51. PubMed ID: 15693083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study.
    Gallot G; Hamidou MA; Clémenceau B; Gaschet J; Tiberghien P; Ferrand C; Vivien R; Barbarot S; Coste-Burel M; Moreau A; Vié H
    Clin Immunol; 2006 Apr; 119(1):79-86. PubMed ID: 16386957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus-specific cytotoxic CD4+ T cells for the treatment of EBV-related tumors.
    Merlo A; Turrini R; Bobisse S; Zamarchi R; Alaggio R; Dolcetti R; Mautner J; Zanovello P; Amadori A; Rosato A
    J Immunol; 2010 May; 184(10):5895-902. PubMed ID: 20385879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
    Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
    Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of virus-specific CD4+ T cells in the control of Epstein-Barr virus infection.
    Mautner J; Bornkamm GW
    Eur J Cell Biol; 2012 Jan; 91(1):31-5. PubMed ID: 21458882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus.
    Delecluse HJ; Feederle R; Behrends U; Mautner J
    Semin Cancer Biol; 2008 Dec; 18(6):409-15. PubMed ID: 18938248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Search for correlation of CD8 T cell response to Epstein-Barr virus with clinical status in rheumatoid arthritis: a 15 month followup pilot study.
    Berthelot JM; Saulquin X; Coste-Burel M; Peyrat MA; Echasserieau K; Bonneville M; Houssaint E
    J Rheumatol; 2003 Aug; 30(8):1673-9. PubMed ID: 12913921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of CD8(+) T lymphocytes specific for lytic and latent antigens of Epstein-Barr virus in healthy virus carriers.
    Benninger-Döring G; Pepperl S; Deml L; Modrow S; Wolf H; Jilg W
    Virology; 1999 Nov; 264(2):289-97. PubMed ID: 10562493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins.
    Adhikary D; Behrends U; Moosmann A; Witter K; Bornkamm GW; Mautner J
    J Exp Med; 2006 Apr; 203(4):995-1006. PubMed ID: 16549597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+ T cell responses in the immune control against latent infection by Epstein-Barr virus.
    Paludan C; Münz C
    Curr Mol Med; 2003 Jun; 3(4):341-7. PubMed ID: 12776989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different contribution of EBV and CMV infections in very long-term carriers to age-related alterations of CD8+ T cells.
    Vescovini R; Telera A; Fagnoni FF; Biasini C; Medici MC; Valcavi P; di Pede P; Lucchini G; Zanlari L; Passeri G; Zanni F; Chezzi C; Franceschi C; Sansoni P
    Exp Gerontol; 2004 Aug; 39(8):1233-43. PubMed ID: 15288697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EBV-specific memory CD8+ T cell phenotype and function in stable solid organ transplant patients.
    Macedo C; Donnenberg A; Popescu I; Reyes J; Abu-Elmagd K; Shapiro R; Zeevi A; Fung JJ; Storkus WJ; Metes D
    Transpl Immunol; 2005 Jun; 14(2):109-16. PubMed ID: 15935301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detailed kinetics of EBV-specific CD4+ and CD8+ T cells during primary EBV infection in a kidney transplant patient.
    Piriou ER; van Dort K; Weel JF; Bemelman FJ; Gamadia LE; van Oers MH; van Baarle D
    Clin Immunol; 2006 Apr; 119(1):16-20. PubMed ID: 16386961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.